HHS Nominee Eyes New Tacks On Drug Prices, Provider Pay
The Trump administration's nominee to lead the U.S. Department of Health and Human Services opened the door Tuesday to new approaches for easing drug prices and basing Medicare reimbursement on the...To view the full article, register now.
Already a subscriber? Click here to view full article